Navigation Links
Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer

iming, design, enrollment and cost of clinical trials; unexpected delays in clinical trials and preparation of materials for submission to the FDA as part of our NDA filing; our ability to establish successful partnerships and collaborations with third parties; the regulatory approval process in the United States and other countries; and our future capital requirements. For further information about these risks and other factors that may affect the actual results achieved by Pharmacyclics, please see the company's reports as filed with the U.S. Securities and Exchange Commission from time to time, including but not limited to its annual report on Form 10-K for the period ended June 30, 2006 and its subsequently filed quarterly reports on Form 10-Q. Forward-looking statements contained in this announcement are made as of this date, and we undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

CONTACT: Leiv Lea of Pharmacyclics, Inc., +1-408-774-0330; or CarolynBumgardner Wang of WeissComm Partners, Inc., +1-415-225-5050, forPharmacyclics, Inc.

Web site: http://www.pharmacyclics.com/

Ticker Symbol: (NASDAQ-NMS:PCYC)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer
2. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
3. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
4. Pharmacyclics Announces Presentations on Its Novel and Selective HDAC and Brutons Tyrosine Kinase Inhibitor Compounds
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:7/22/2014)...  Decision Resources Group finds that over ... currently treated with Biogen Idec,s oral disease-modify ... and/or gastrointestinal events while on the therapy. ... these side effects, signifying either their transient ... such events. In the end, fewer than ...
(Date:7/22/2014)... 22, 2014 BiologicTx ® today announced ... 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s proprietary ... July 9 at the Miami Transplant Institute, located at ... Kidney Paired Donation (KPD) is ... for kidney transplant with one another due to incompatible ...
(Date:7/22/2014)... Wis. , July 22, 2014  PuraMed ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... sponsor of Operation Troop Aid. "We ... Russell Mitchell , CEO and Chairman of ... and women in combat zones experience migraines much ...
Breaking Medicine Technology:Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 2PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 3
... Eli Lilly and Company (NYSE: LLY ) ... cost-effectiveness of insulin lispro mix 75/25 and insulin lispro mix ... analysis indicated that for patients with type 2 diabetes who ... are likely to be cost-effective when compared to LAIA in ...
... Sanofi (EURONEXT: SAN and NYSE: SNY ... once-daily GLP-1 receptor agonist Lyxumia® (lixisenatide) that  is in ... results in type 2 diabetes patients not at goal ... are being presented or published at the American Diabetes ...
Cached Medicine Technology:Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 2Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 3Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 4Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 5Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 6Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 7Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 2Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 3Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 4Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 5Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 6Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 7Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 8
(Date:7/22/2014)... Washington, DC (PRWEB) July 22, 2014 Ticket ... vs. Inter Milan tickets at Fedex Field in Landover, MD. ... Sates to be a fan of international soccer. After the success ... in Brazil, soccer fever is alive and well. One way that ... hunger for the sport is with the 2014 Guinness International Champions ...
(Date:7/22/2014)... 2014 The park is the heart ... Kendalltown Homeowners Association, Inc., made a recent investment ... with the purchase of playground equipment from American Parks ... beautiful Miami Florida, and is a 475-unit community that ... surrounding landscape has created a tropical paradise with lush ...
(Date:7/22/2014)... By Kathleen Doheny ... -- Removing the uterus with a minimally invasive procedure known ... now a new study pinpoints the likelihood more clearly. ... undetected uterine cancer at the time of the procedure, researchers ... age of 65. Surgeons performing a hysterectomy with morcellation ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 CarePoint Health is ... elected as the President of the medical staff at Bayonne ... will serve as President, as voted on by the physicians ... the medical staff in relation to the administration at Bayonne ... of physicians and to work to make the Medical Center ...
(Date:7/22/2014)... Latin America Drilling fluid and Completion fluid Market Report defines ... Latin America with analysis and forecast of revenue. The drilling ... to grow from around $0.93 billion in 2013 to $1.45 ... given period. , Browse through the TOC of the Latin ... an idea of the in-depth analysis provided. This also provides ...
Breaking Medicine News(10 mins):Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3Health News:Fun in the Florida Sun: Kendalltown Homeowners Association Inc. Expands Outdoor Recreation with American Parks Company™ 2Health News:Fun in the Florida Sun: Kendalltown Homeowners Association Inc. Expands Outdoor Recreation with American Parks Company™ 3Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 2Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 3Health News:Dr. Howard Levine Elected President of the Medical Staff at Bayonne Medical Center 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 6
... 59 feet-long articulated vehicle using the latest satellite technology developed ... year.// ,The unit will conduct the high-speed transfer of ... Cancer. Besides this, health check ups for men and support ... first of its kind in Europe. ,According to Action ...
... most rural counties of the United States are hospitalized ... //by HHS Agency for Healthcare Research and Quality and ... Ambulatory Pediatrics. ,The study, which was led by ... of health care, health status, and other measures for ...
... organization, National Dairy Development Board (NDDB), is like the ... rolled out its batch of DNA Hepatitis –B Vaccine//, ... compared to the other brands in the market. ... at its facility in Gachibowli, will be sold under ...
... Alcohol consumption has been linked with violence and increased homicide ... increased, there has been a decrease in the number of ... has brought done the violence as well as homicide, a ... October issue of Alcoholism: Clinical & Experimental Research. ...
... endeavour to run 24-half marathons in 24 consecutive days will ... also give// publicity to his employer. ,Young ran ... and took another step towards the noble cause. ... supported me in my endeavour to raise 100,000 pounds for ...
... Pradesh may raise the retirement age of medical specialists and ... order to provide due healthcare to people. , ,"Providing ... of the state government and for this the government will ... needed, special allowance will also be provided to them," Chief ...
Cached Medicine News:Health News:Big Bus, the ?1.5m Cancer Bus Hits the roa 2Health News:Local Health Care Limited for Rural Children 2Health News:Alcoholics Anonymous: A Blessing For The Addicted 2Health News:Alcoholics Anonymous: A Blessing For The Addicted 3Health News:Cancer Survivor Runs Half-marathon 2
ACMI™ COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument....
... An in vitro Nucleic Acid ... using Microplate Chemiluminescence for the ... (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 ... Lowand High-Risk Groups in Cervical ...
An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45,...
... AS100 Analyzer is designed ... regardless of the sample ... launched in December 2004, ... in May 2005. Assays ...
Medicine Products: